638213-98-6
638213-98-6
Chemical Structure
AGL-2263
- CAS No.: 638213-98-6
- Formula:C17H10N2O5
- Molecular Weight:322.27
IUPAC Name: (E)-2-(3,4-dihydroxybenzoyl)-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)acrylonitrile
InChIKey: IUGRBTCJEYEDIY-VZUCSPMQSA-N
SMILES: O=C(C1=CC(O)=C(O)C=C1)/C(C#N)=C/C2=CC=C(OC3=O)C(N3)=C2
Biological Activity: AGL-2263 is an insulin receptor and insulin-like growth factor (IGF) receptor inhibitor[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AGL-2263 | 98.31% | AGL-2263 is an insulin receptor and insulin-like growth factor (IGF) receptor inhibitor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Li Y, et al. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake. Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5697-705. [Content Brief]
- [2]. Hua Zhang, et al. Somatic cells initiate primordial follicle activation and govern the development of dormant oocytes in mice. Curr Biol. 2014 Nov 3;24(21):2501-8. [Content Brief]
Keywords
